Study of EGFR Signaling in Nasopharyngeal Carcinoma Cells
Author Information
Author(s): Ruan Lin, Li Xin-Hui, Wan Xun-Xun, Yi Hong, Li Cui, Li Mao-Yu, Zhang Peng-Fei, Zeng Gu-Qing, Qu Jia-Quan, He Qiu-Yan, Li Jian-Huang, Chen Yu, Chen Zhu-Chu, Xiao Zhi-Qiang
Primary Institution: Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, China
Hypothesis
The study aims to identify novel downstream proteins of the EGFR signaling pathway in nasopharyngeal carcinoma cells.
Conclusion
The study identified 33 EGFR-regulated phosphoproteins and demonstrated that GSTP1 is involved in chemoresistance in nasopharyngeal carcinoma cells.
Supporting Evidence
- 33 nonredundant phosphoproteins were identified, including five known EGFR-regulated proteins.
- GSTP1 was shown to contribute to paclitaxel resistance in EGF-stimulated CNE2 cells.
- An EGFR signaling network was constructed based on the identified phosphoproteins.
Takeaway
Researchers looked at how a protein called EGFR works in cancer cells and found new proteins that help it do its job, which could help in treating cancer better.
Methodology
The study used quantitative phosphoproteomics, including 2D-DIGE and mass spectrometry, to analyze phosphoproteins in NPC cells.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website